---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-072467"
form_type: "8-K"
ticker: "PYXS"
cik: "0001782223"
company_name: "Pyxis Oncology, Inc."
filed_at: "2024-06-12T23:59:59+00:00"
generated_at: "2026-06-01T04:52:39.303860+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Pyxis Oncology stockholders elect four directors, ratify Ernst & Young as auditor

## Summary
- Dr. Santhosh Palani elected Class I director with 28,241,400 for, 93,674 withheld.
- Class III directors elected: John Flavin (21,045,395 for), Lara Sullivan (24,369,861), Jakob Dupont (28,220,452).
- Ratification of Ernst & Young as FY2024 auditor passed with 42,153,375 for, 151,087 against, 31,729 abstain.
- Quorum of 42,336,191 shares present from 58,876,390 outstanding as of record date April 18, 2024.

## SEC filing metadata
- accession: 0000950170-24-072467
- form_type: 8-K
- ticker: PYXS
- cik: 0001782223
- company_name: Pyxis Oncology, Inc.
- filed_at: 2024-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782223/000095017024072467/0000950170-24-072467-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782223/000095017024072467/pyxs-20240611.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-072467
- JSON: https://secwatch.observer/filing/0000950170-24-072467.json
- Plain text: https://secwatch.observer/filing/0000950170-24-072467.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.